Catalyst Pharmaceuticals Inc (CPRX) — Working Capital to Net Assets Ratio
Catalyst Pharmaceuticals Inc (CPRX) has a Working Capital to Net Assets ratio of 79.8% as of March 2026. Working capital of $807.99 Million (current assets of $940.39 Million minus current liabilities of $132.40 Million) is measured against net assets of $1.01 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can Catalyst Pharmaceuticals Inc fund operations to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Catalyst Pharmaceuticals Inc Working Capital to Net Assets (2004–2025)
This chart shows how Catalyst Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2004 to 2025. As of March 2026, the ratio stands at 79.8%, reflecting working capital of $807.99 Million against net assets of $1.01 Billion USD. For the complete balance sheet picture, see Catalyst Pharmaceuticals Inc balance sheet assets.
Annual Working Capital to Net Assets for Catalyst Pharmaceuticals Inc (2004–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Catalyst Pharmaceuticals Inc from 2004 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Catalyst Pharmaceuticals Inc (CPRX) asset resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 78.3% | $746.88 Million | $954.27 Million | $894.03 Million | $147.15 Million | ▲ +9.1 pp |
| 2024 | 69.1% | $502.93 Million | $727.63 Million | $623.61 Million | $120.68 Million | ▲ +32.2 pp |
| 2023 | 36.9% | $143.27 Million | $387.88 Million | $219.33 Million | $76.06 Million | ▼ -50.7 pp |
| 2022 | 87.6% | $263.22 Million | $300.42 Million | $320.81 Million | $57.59 Million | ▼ -0.9 pp |
| 2021 | 88.5% | $183.04 Million | $206.83 Million | $210.11 Million | $27.06 Million | ▲ +8.0 pp |
| 2020 | 80.5% | $136.49 Million | $169.60 Million | $159.24 Million | $22.76 Million | ▼ -19.1 pp |
| 2019 | 99.6% | $87.26 Million | $87.63 Million | $111.36 Million | $24.10 Million | ▲ +9.6 pp |
| 2018 | 89.9% | $45.68 Million | $50.78 Million | $55.19 Million | $9.51 Million | ▼ -10.0 pp |
| 2017 | 99.9% | $80.92 Million | $80.96 Million | $85.19 Million | $4.27 Million | ▼ -0.2 pp |
| 2016 | 100.1% | $39.36 Million | $39.31 Million | $41.45 Million | $2.09 Million | ▼ -1.6 pp |
| 2015 | 101.8% | $56.46 Million | $55.48 Million | $59.90 Million | $3.44 Million | ▼ -6.0 pp |
| 2014 | 107.7% | $37.97 Million | $35.24 Million | $43.83 Million | $5.86 Million | ▼ -0.6 pp |
| 2013 | 108.4% | $23.18 Million | $21.39 Million | $25.32 Million | $2.14 Million | ▲ +5.2 pp |
| 2012 | 103.1% | $15.08 Million | $14.62 Million | $16.73 Million | $1.65 Million | ▼ -40.3 pp |
| 2011 | 143.4% | $5.39 Million | $3.76 Million | $6.23 Million | $833.80K | ▲ +44.2 pp |
| 2010 | 99.3% | $5.48 Million | $5.52 Million | $5.78 Million | $298.96K | ▼ -0.4 pp |
| 2009 | 99.7% | $7.59 Million | $7.62 Million | $7.89 Million | $294.15K | ▲ +0.4 pp |
| 2008 | 99.3% | $10.49 Million | $10.56 Million | $11.92 Million | $1.43 Million | ▼ -0.1 pp |
| 2007 | 99.4% | $16.23 Million | $16.32 Million | $16.53 Million | $303.29K | ▼ -0.4 pp |
| 2006 | 99.8% | $19.81 Million | $19.85 Million | $20.59 Million | $772.85K | ▲ +3.8 pp |
| 2005 | 96.0% | $428.58K | $446.46K | $771.57K | $342.99K | ▼ -2.8 pp |
| 2004 | 98.8% | $116.11K | $117.58K | $183.91K | $67.80K | — |